编造重大虚假内容，上市首年虚增收入3000万！知名“减肥药概念股”公司及实控人等被罚7620万元

Core Viewpoint - ST Nuotai has faced administrative penalties from the China Securities Regulatory Commission (CSRC) and disciplinary actions from the Shanghai Stock Exchange due to significant violations, including fabricating major false content in public issuance documents [1][17]. Group 1: Administrative Penalties - ST Nuotai received a total fine of 76.2 million yuan from the CSRC, which includes 47.4 million yuan for the fabrication of major false content in its public issuance documents [17][20]. - The company and its actual controller, Zhao Dezhong, along with five other executives, were penalized for violations related to the 2021 annual report, which falsely inflated revenue and profit figures [19][21]. Group 2: Financial Misreporting - The 2021 annual report of ST Nuotai included a false revenue recognition of 30 million yuan, which was derived from capital increase funds rather than legitimate business transactions, leading to an inflated profit total of 25.95 million yuan, accounting for 20.64% of the reported profit [19][20]. - The CSRC's investigation revealed that the financial information in the company's bond issuance prospectus contained significant false content [20]. Group 3: Company Background and Operations - ST Nuotai, established in 2009 and listed on the Sci-Tech Innovation Board in 2021, focuses on the research and development of peptide drugs and small molecule drugs, combining independent research with customized production [22][24]. - The company has been involved in the development of various pharmaceutical products, particularly in the peptide sector, and has a dual-driven development model focusing on both self-selected and customized products [22][24]. Group 4: Recent Developments and Market Position - As of December 18, ST Nuotai's stock price was 38.38 yuan per share, with a total market capitalization of 12.1 billion yuan [28]. - The company reported a revenue of 1.527 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 21.95%, and a net profit of 445 million yuan, up 26.92% year-on-year [26].